Pfizer Submits Data for COVID-19 Vaccine in Children 5 to 11

Pfizer COVID-19 vaccines are seen kept on the table at the Christine E. Lynn Rehabilitation Center in Miami, Fla., on April 15, 2021. Chandan Khanna/AFP via Getty Images

Pfizer and its German partner on Tuesday said they submitted data concerning results of a COVID-19 vaccine trial in children as young as 5.

Pfizer and BioNTech sent the data to the U.S. Food and Drug Administration (FDA).